Affimed NV (AFMD) formed inverse H&S with $2.40 target or 9.00% above today’s $2.20 share price. Affimed NV (AFMD) has $87.77M valuation. The stock increased 6.02% or $0.12 on April 24, reaching $2.2. About shares traded. Affimed NV (NASDAQ:AFMD) has declined 27.85% since September 16, 2016 and is downtrending. It has underperformed by 38.84% the S&P500.
Among 28 analysts covering Glencore PLC (LON:GLEN), 17 have Buy rating, 3 Sell and 8 Hold. Therefore 61% are positive. Glencore PLC had 365 analyst reports since July 23, 2015 according to SRatingsIntel. The company was maintained on Friday, July 31 by Citigroup. J.P. Morgan maintained it with “Overweight” rating and GBX 130 target in Monday, January 18 report. Liberum Capital maintained it with “Hold” rating and GBX 125 target in Tuesday, November 3 report. The firm has “Buy” rating given on Thursday, February 18 by Citigroup. The firm earned “Hold” rating on Tuesday, September 29 by Jefferies. The firm has “Hold” rating given on Thursday, July 23 by Jefferies. Bernstein maintained Glencore PLC (LON:GLEN) rating on Monday, February 1. Bernstein has “Outperform” rating and GBX 145 target. Liberum Capital maintained the shares of GLEN in report on Thursday, December 15 with “Hold” rating. The firm has “Outperform” rating given on Tuesday, January 19 by Bernstein. The rating was maintained by RBC Capital Markets on Monday, September 14 with “Outperform”. See Glencore PLC (LON:GLEN) latest ratings:
25/04/2017 Broker: Goldman Sachs Rating: Buy New Target: GBX 365.00 Maintain
21/04/2017 Broker: Barclays Capital Rating: Overweight Old Target: GBX 390.00 New Target: GBX 400.00 Maintain
21/04/2017 Broker: Credit Suisse Rating: Outperform Maintain
19/04/2017 Broker: Credit Suisse Rating: Outperform Old Target: GBX 410.00 New Target: GBX 410.00 Maintain
18/04/2017 Broker: Jefferies Rating: Buy Old Target: GBX 380.00 New Target: GBX 380.00 Maintain
03/04/2017 Broker: Jefferies Rating: Buy Old Target: GBX 380.00 New Target: GBX 380.00 Maintain
30/03/2017 Broker: Credit Suisse Rating: Outperform Old Target: GBX 400.00 New Target: GBX 410.00 Maintain
28/03/2017 Broker: BNP Paribas Rating: Outperform Old Target: GBX 405.00 New Target: GBX 405.00 Maintain
28/03/2017 Broker: Macquarie Research Rating: Neutral Old Target: GBX 340.00 New Target: GBX 340.00 Maintain
27/03/2017 Broker: Barclays Capital Rating: Overweight Old Target: GBX 390.00 New Target: GBX 390.00 Maintain
Among 7 analysts covering Affimed Therapeutics (NASDAQ:AFMD), 4 have Buy rating, 0 Sell and 3 Hold. Therefore 57% are positive. Affimed Therapeutics had 13 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Affimed NV (NASDAQ:AFMD) earned “Hold” rating by Jefferies on Thursday, May 19. The firm earned “Sell” rating on Monday, August 10 by Zacks. Jefferies initiated Affimed NV (NASDAQ:AFMD) rating on Wednesday, September 9. Jefferies has “Hold” rating and $11 target. Oppenheimer maintained it with “Outperform” rating and $19 target in Thursday, August 6 report. The stock has “Hold” rating by Zacks on Thursday, September 3. Laidlaw initiated the stock with “Buy” rating in Thursday, December 10 report. The firm has “Outperform” rating given on Tuesday, April 12 by BMO Capital Markets. The rating was initiated by Wells Fargo with “Outperform” on Friday, December 4. The rating was downgraded by Leerink Swann to “Market Perform” on Friday, August 12. As per Thursday, May 19, the company rating was downgraded by Leerink Swann.
Glencore plc is an integrated producer and marketer of commodities, such as metals and minerals, energy products, agricultural products and Corporate and other. The company has market cap of 44.69 billion GBP. The Metals and minerals segment is engaged in copper, zinc/lead, nickel, ferroalloys, alumina/aluminum and iron ore production and marketing. It currently has negative earnings. It also has interests in industrial assets that include mining, smelting, refining and warehousing operations.
About 14.72 million shares traded. Glencore PLC (LON:GLEN) has risen 44.44% since September 23, 2016 and is uptrending. It has outperformed by 33.46% the S&P500.
